FIP seeks oral-fluid testing, higher random drug testing coverage for pilots | India News


FIP seeks oral-fluid testing, higher random drug testing coverage for pilots
Pilots seek oral-fluid screening, 20-25% annual random checks. Photo credit: ANI

MUMBAI: The Federation of Indian Pilots (FIP) has written to the Directorate General of Civil Aviation (DGCA) seeking the introduction of oral-fluid testing as a complementary method alongside urine-based screening. It also recommended that the annual random psychoactive substance testing for pilots be raised from the current 10 % minimum to at least 20-25 %.The FIP recommendation comes in wake of the brouhaha over the positive drug test result for an Air India pilot who operated the Aug 03 Phuket to Delhi flight. The aircraft dropped 300 feet enroute when over Odisha, injuring 20 passengers and 4 passengers. Aircraft technical fault involving a triple hydraulic failure is another critical aspect under scrutiny by the investigating agency.Citing precedents from Australia’s CASA, the US’s Department of Transportation and the UAE’s GCAA, all of which permit oral-fluid testing alongside urine testing in regulated frameworks, FIP proposed a “risk-based hybrid model” in which oral fluid is used for random, high-volume and airport-based screening, while urine testing is retained where a longer detection window or specific medical requirements apply. It said an illustrative planning estimate, 15 minutes for oral fluid collection versus 45 minutes for urine, suggested oral-fluid testing could cut collection workload by about two-thirds. FIP though added that these numbers need validation and proposed a 12-month controlled pilot programme before wider roll out.“While the existing urine-testing system has an established regulatory and laboratory framework, FIP believes that the increasing scale of Indian aviation operations warrants consideration of additional testing methodologies that can increase testing capacity, reduce operational disruption and facilitate rapid testing at airports and other operational locations,” the letter said.Since neither method directly measures impairment, FIP said that any revised framework must preserve the sequence of screening, confirmatory lab testing and medical review before a final regulatory determination, especially to account for over-the-counter medication that could trigger a non-negative result.

Share your thoughts in the comments